CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
92 hedge funds and large institutions have $215M invested in Concert Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 31 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 93 → 92 (-1)
Holders
92
Holding in Top 10
–
Calls
$3.45M
Puts
$2.44M
Top Buyers
| 1 | +$10.9M | |
| 2 | +$3.99M | |
| 3 | +$2.84M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.44M |
| 5 |
Barclays
London,
United Kingdom
|
+$1.02M |
Top Sellers
| 1 | -$7.2M | |
| 2 | -$6.99M | |
| 3 | -$2.23M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.46M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.33M |